Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

OMEPRAZOLE EXTENDED-RELEASE CAPSULES

Awarded
SPE2DP26F8098Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency has awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of OMEPRAZOLE EXTENDED-RELEASE CAPSULES with NSN 6505014153580. The award, issued on July 24, 2026, carries a total contract value of $41.06 and was posted through the DIBBS system under solicitation number SPE2DP26F8098. The contract is categorized as a federal award with no specified set-aside type or NAICS code, and performance is expected to fall under the jurisdiction of the Department of Defense. The item is procured under the agency’s pharmaceutical supply chain to support military and defense medical needs. Although no specific delivery location or point of contact is detailed in the contract data, the award is linked to the broader logistics framework managed by the Defense Logistics Agency. The contract documentation, accessible via the provided DIBBS link, serves as a formal record of procurement, ensuring traceability and compliance within the federal supply system for essential medications.

General Info

DLA awards DMS PHARMACEUTICAL $41.06 for omeprazole capsules to support defense medical needs.

Agency

Department Of Defense → Defense Logistics AgencyView Agency

Contract Value

$41.06

NAICS

424210 - Drugs and Druggists' Sundries Merchant WholesalersView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Awardee

DMS PHARMACEUTICAL GROUP INCView Profile

Award Issued Date

Documents

(2)

SPE2DP26F8098.pdf

PDF

SPE2DP26F8098.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Organization / Agency
Department Of Defense → Defense Logistics Agency
View Agency Profile
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F8098 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $41.06 Award Date: 07-24-2026 Delivery order under: SPE2DX25D9900 Line items: - OMEPRAZOLE EXTENDED-RELEASE CAPSULES (NSN/Part 6505014153580, PR 7017626058)

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
DIBBS
REHYDRATION SALTS FOR
Solicitation # SPE2DP-26-T-4988
Solicitation SPE2DP-26-T-4988 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of lemon-flavored electrolyte oral rehydration powder. The requirement is for three packages, with each package containing 100 packets of 21 grams each. Each packet is formulated to provide 665 mg of sodium, 390 mg of potassium, 80 mg of citrate, 83 mg of magnesium, and 3 mg of zinc when dissolved in 16.9 fluid ounces of solution. The specified product is Drip Drop Hydration Inc. part number 61406 under NSN 6505-01-646-2692, and it must have a non-extendable shelf life of 24 months. Delivery is required within 20 days of award, with a required delivery date of September 9, 2026. The shipment is FOB Destination to the USS Tucson (SSN 770) at FPO AP 96679. Inspection and acceptance will also occur at the destination. Packaging must be commercial and compliant with DLA Packaging Requirements for Procurement (RP001) and ASTM D3951, unless the material is deemed hazardous per FED-STD-313, in which case TQ requirement IP025 applies. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The award process may be automated, and the contract incorporates various federal regulations, including the Buy American Act, Berry Amendment, and DFARS cybersecurity standards for safeguarding covered defense information.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS